Will Bayer Supplement-Drug Combo Draw Other Firms Into New Market?
FDA's silence about Bayer's launch of Aspirin with Heart Advantage could speak volumes about a possible new marketing opportunity
FDA's silence about Bayer's launch of Aspirin with Heart Advantage could speak volumes about a possible new marketing opportunity